MultimediaAlthough levodopa is effective for treating Parkinson disease, physicians and patients face significant management challenges related to disease progression. Patients may develop fluctuations in motor symptoms and dyskinesias as well as nonmotor symptoms. Review this CME Brief Report activity to learn about new and emerging treatment options to manage patients’ symptoms. [top]

Parkinson Disease: Current Trends in Treatment and Unmet Needs

Parkinson Disease: Current and Emerging Treatment Strategies

Adolfo Ramirez-Zamora, MD

[Activity] [Posttest] 3/31/2020

Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder

Diagnosing Bipolar Disorder in Pediatric Patients

Kiki D. Chang, MD

[Activity] [Posttest] 1/31/2020

Treating Bipolar Disorder in Adolescents

Robert L. Findling, MD, MBA

[Activity] [Posttest] 1/31/2020

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management

Larry Culpepper, MD, MPH (Chair); Raymond W. Lam, MD, FRCPC; and Roger S. McIntyre, MD, FRCPC

[Activity] [Posttest] 1/31/2020

Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment

Larry Culpepper, MD, MPH

[Activity] [Posttest] 10/31/2019

Impact of Cognitive Impairment on Functioning in Patients With Depression

Raymond W. Lam, MD, FRCPC

[Activity] [Posttest] 8/31/2019

Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder

Roger S. McIntyre, MD, FRCPC

[Activity] [Posttest] 8/31/2019

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Christoph U. Correll, MD, and John Lauriello, MD

[Activity] [Posttest] 12/31/2019

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

Evidence-Based Strategies for Managing Tardive Dyskinesia

Joseph P. McEvoy, MD

[Activity] [Posttest] 11/30/2019

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

J. Sloan Manning, MD, Joseph P. McEvoy, MD

[Activity] [Posttest] 11/30/2019

Discussing the Risk of Tardive Dyskinesia With Patients and Screening for Signs

J. Sloan Manning, MD

[Activity] [Posttest] 11/30/2019

Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice

Assessing and Treating Insomnia in Patients With Psychiatric Disorders, Part 1

Ruth M. Benca, MD, PhD (Chair), and Daniel J. Buysse, MD

[Activity] [Posttest] 11/30/2019

Assessing and Treating Insomnia in Patients With Psychiatric Disorders, Part 2

Ruth M. Benca, MD, PhD (Chair), and Daniel J. Buysse, MD

[Activity] [Posttest] 11/30/2019

Improving Remission Rates in Major Depressive Disorder: A Case-Based Approach

Improving Remission Rates in Major Depressive Disorder: A Case-Based Approach

Roger S. McIntyre, MD, FRCPC

[Activity] [Posttest] 11/30/2018

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Assessing Patients for Tardive Dyskinesia

John M. Kane, MD

[Activity] [Posttest] 8/31/2019

Comparing Treatments for Tardive Dyskinesia

Leslie L. Citrome, MD, MPH

[Activity] [Posttest] 8/31/2019

Epidemiology and Prevention of Tardive Dyskinesia

Christoph U. Correll, MD

[Activity] [Posttest] 7/31/2019

Advanced Topics in Major Depressive Disorder: Practical Strategies to Improve Remission

Advanced Topics in Major Depressive Disorder: Practical Strategies to Improve Remission

Rakesh Jain, MD, MPH

[Activity] [Posttest] 4/30/2019